Literature DB >> 11848705

A database of [(11)C]WAY-100635 binding to 5-HT(1A) receptors in normal male volunteers: normative data and relationship to methodological, demographic, physiological, and behavioral variables.

Eugenii A Rabiner1, Cristina Messa, Peter A Sargent, Karen Husted-Kjaer, Andrew Montgomery, Andrew D Lawrence, Christopher J Bench, Roger N Gunn, Phillip Cowen, Paul M Grasby.   

Abstract

PET studies of [(11)C]WAY-100635 binding are proving to be a useful tool to evaluate 5-HT(1A) receptor function in vivo in humans. We describe the pattern of [(11)C]WAY-100635 binding in 61 healthy male brains and examine its variability. For all PET scans, binding potential (BP) values for [(11)C]WAY-100635 in different regions were calculated using a simplified reference tissue model, with the cerebellum as reference region. Specifically we describe (1) region of interest and SPM databases of PET [(11)C]WAY-100635 binding, including test-retest variability; (2) the sensitivity of [(11)C]WAY-100635 binding to manipulations of endogenous 5-HT; and (3) correlations between [(11)C]WAY-100635 binding and radiochemical, demographic, physiological, and behavioral variables. The regional distribution of [(11)C]WAY-100635 binding in healthy human brain was similar to that reported in vitro. The test-retest variability was approximately 12% (range 9-16%) and was similar for all methods of regional sampling. The binding of [(11)C]WAY-100635 was insensitive to changes in brain 5-HT induced by tryptophan infusion and depletion. Although BP values varied greatly across subjects (range 2.9-6.8), there were no significant correlations of regional and global BP with common radiochemical, demographic, physiological, and personality variables. Specifically, in contrast with two recent small studies, we found no decline of [(11)C]WAY-100635 binding with age in our large cohort over the age range of 24 to 53 years. Assessment of 5-HT(1A) receptors in vivo using PET and [(11)C]WAY-100635 gives reliable measures of 5-HT(1A) binding. The large between-subject variability observed could not be explained by common methodological, physiological, or behavioral factors and hence the biological basis of this variability remains to be clarified. ©2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11848705     DOI: 10.1006/nimg.2001.0984

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  41 in total

1.  Differential modulation of the default mode network via serotonin-1A receptors.

Authors:  Andreas Hahn; Wolfgang Wadsak; Christian Windischberger; Pia Baldinger; Anna S Höflich; Jan Losak; Lukas Nics; Cécile Philippe; Georg S Kranz; Christoph Kraus; Markus Mitterhauser; Georgios Karanikas; Siegfried Kasper; Rupert Lanzenberger
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

Review 2.  The development, past achievements, and future directions of brain PET.

Authors:  Terry Jones; Eugenii A Rabiner
Journal:  J Cereb Blood Flow Metab       Date:  2012-03-21       Impact factor: 6.200

3.  5-HT₁A receptor binding is increased after recovery from bulimia nervosa compared to control women and is associated with behavioral inhibition in both groups.

Authors:  Ursula F Bailer; Cinnamon S Bloss; Guido K Frank; Julie C Price; Carolyn C Meltzer; Chester A Mathis; Mark A Geyer; Angela Wagner; Carl R Becker; Nicholas J Schork; Walter H Kaye
Journal:  Int J Eat Disord       Date:  2010-09-24       Impact factor: 4.861

4.  Age and sex effects on 5-HT(4) receptors in the human brain: a [(11)C]SB207145 PET study.

Authors:  Karine Madsen; Mette T Haahr; Lisbeth Marner; Sune H Keller; William F Baaré; Claus Svarer; Steen G Hasselbalch; Gitte M Knudsen
Journal:  J Cereb Blood Flow Metab       Date:  2011-03-02       Impact factor: 6.200

5.  First-in-human evaluation of 18F-mefway, a PET radioligand specific to serotonin-1A receptors.

Authors:  Ansel T Hillmer; Dustin W Wooten; Alisha K Bajwa; Andrew T Higgins; Patrick J Lao; Tobey J Betthauser; Todd E Barnhart; Howard A Rowley; Charles K Stone; Sterling C Johnson; Jogeshwar Mukherjee; Bradley T Christian
Journal:  J Nucl Med       Date:  2014-11-13       Impact factor: 10.057

6.  Reduced serotonin receptors and transporters in normal aging adults: a meta-analysis of PET and SPECT imaging studies.

Authors:  Teresa M Karrer; Casey L McLaughlin; Carmela P Guaglianone; Gregory R Samanez-Larkin
Journal:  Neurobiol Aging       Date:  2019-04-05       Impact factor: 4.673

7.  A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans.

Authors:  Sean P David; Naga Venkatesha Murthy; Eugenii A Rabiner; Marcus R Munafó; Elaine C Johnstone; Robyn Jacob; Robert T Walton; Paul M Grasby
Journal:  J Neurosci       Date:  2005-03-09       Impact factor: 6.167

Review 8.  Imaging the serotonin 1A receptor using [11C]WAY100635 in healthy controls and major depression.

Authors:  Natalie Hesselgrave; Ramin V Parsey
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-02-25       Impact factor: 6.237

Review 9.  The serotonergic system and anxiety.

Authors:  Joshua A Gordon; Rene Hen
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

10.  Elevated serotonin 1A binding in remitted major depressive disorder: evidence for a trait biological abnormality.

Authors:  Jeffrey M Miller; Kathleen G Brennan; Todd R Ogden; Maria A Oquendo; Gregory M Sullivan; J John Mann; Ramin V Parsey
Journal:  Neuropsychopharmacology       Date:  2009-05-20       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.